Osaic Holdings’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89K | Buy |
+253
| New | +$4.89K | ﹤0.01% | 6152 |
|
|
2025
Q1 | – | Sell |
-447
| Closed | -$10.7K | – | 7262 |
|
|
2024
Q4 | $10.7K | Hold |
447
| – | – | ﹤0.01% | 5701 |
|
|
2024
Q3 | $12.5K | Hold |
447
| – | – | ﹤0.01% | 5617 |
|
|
2024
Q2 | $11.3K | Hold |
447
| – | – | ﹤0.01% | 5634 |
|
|
2024
Q1 | $13K | Hold |
447
| – | – | ﹤0.01% | 5550 |
|
|
2023
Q4 | $10.9K | Hold |
447
| – | – | ﹤0.01% | 5755 |
|
|
2023
Q3 | $8.77K | Sell |
447
-300
| -40% | -$5.89K | ﹤0.01% | 5950 |
|
|
2023
Q2 | $17.9K | Buy |
747
+73
| +11% | +$1.75K | ﹤0.01% | 5620 |
|
|
2023
Q1 | $14.8K | Hold |
674
| – | – | ﹤0.01% | 5728 |
|
|
2022
Q4 | $17K | Sell |
674
-9,660
| -93% | -$244K | ﹤0.01% | 5653 |
|
|
2022
Q3 | $253K | Buy |
10,334
+985
| +11% | +$24.1K | ﹤0.01% | 3529 |
|
|
2022
Q2 | $202K | Buy |
9,349
+6,800
| +267% | +$147K | ﹤0.01% | 3783 |
|
|
2022
Q1 | $72K | Sell |
2,549
-56
| -2% | -$1.58K | ﹤0.01% | 4815 |
|
|
2021
Q4 | $101K | Sell |
2,605
-300
| -10% | -$11.6K | ﹤0.01% | 4585 |
|
|
2021
Q3 | $133K | Buy |
2,905
+70
| +2% | +$3.21K | ﹤0.01% | 4274 |
|
|
2021
Q2 | $141K | Sell |
2,835
-1,568
| -36% | -$78K | ﹤0.01% | 4186 |
|
|
2021
Q1 | $226K | Sell |
4,403
-175
| -4% | -$8.98K | ﹤0.01% | 3619 |
|
|
2020
Q4 | $227K | Sell |
4,578
-10,315
| -69% | -$511K | ﹤0.01% | 3361 |
|
|
2020
Q3 | $580K | Sell |
14,893
-447
| -3% | -$17.4K | ﹤0.01% | 2302 |
|
|
2020
Q2 | $663K | Buy |
15,340
+6,719
| +78% | +$290K | ﹤0.01% | 2098 |
|
|
2020
Q1 | $253K | Buy |
+8,621
| New | +$253K | ﹤0.01% | 2683 |
|